3T Biosciences

3T is an immunotherapy company developing next-generation, transformative therapies for broad patient populations.

[3T Biosciences @3tbio]

We’re thrilled to announce the debut of 3T Biosciences with $40M in Series A financing! Born out of a lab at @Stanford, 3T is developing transformative therapies for the treatment of solid tumors and other diseases.

https://t.co/AHmkjkwhci

@lightspeedvp @BioWestlake @parkerici

[3T Biosciences @3tbio]

Today is #RareDiseaseDay, bringing awareness to rare diseases and the patients and caregivers whose lives they disrupt. We aim to provide hope to patients with rare cancers and other diseases that don't receive the same resources, funding and attention as more common diseases.

[3T Biosciences @3tbio]

3T is pleased to announce that we’ve joined forces with Boehringer Ingelheim to develop next-generation cancer therapies.

Read more about the strategic collaboration and licensing agreement: https://t.co/A15u8K7OFR @Boehringer

#immunotherapy #biotech #TCR

[3T Biosciences @3tbio]

3T Biosciences is honored to welcome John Leonard, M.D. to our Board of Directors.

Dr. Leonard has 30+ years of industry leadership experience at @AbbVie, @Abbott, and now @intelliatx, where he currently serves as CEO.

Welcome, Dr. Leonard: https://t.co/BD3V9nvAzt

[BioSpace @biospace]

With $40 million in hand, @3tbio launched Thursday with a technology platform its leadership team believes can change the future of treatment for solid tumors and immune-mediated diseases.
#3TBiosciences #Biotech #Immunotherapy #BioSpace
https://t.co/H0g5M2oaw1

[Stanford Office of Technology Licensing (OTL) @StanfordOTL]

🎉Congrats 3T Biosciences: $40 M SERIES A FINANCING! Leveraging the power of immune system to recognize, target, and destroy cancer cells: advancing the development of next-gen therapies with potential to be safer, more effective, and even curative for difficult-to-treat cancer

[3T Biosciences @3tbio]

@3TBio is pleased to announce CEO Stefan J. Scherer M.D., Ph.D. will be presenting at this year's @PMWCintl - Precision Medicine World Conference 2022 Silicon Valley.

The event starts tomorrow. You can register for this year's event and learn more here:

https://t.co/VOw03n5Qws

[3T Biosciences @3tbio]

@3tbio is pleased to announce co-founder @marvzipan will be presenting at this year's TCR-based Therapies for Solid Tumors Summit, taking place June 27 - 29 in Boston, MA.

Register to attend this year's event and learn more here:

https://t.co/gE6J25JIg0

#tcr #immunotherapy

[3T Biosciences @3tbio]

@3tbio would like to congratulate scientific advisory board member Christina Curtis on winning @AACR's Award for Outstanding Achievement In Basic Cancer Research.

You can read @AACR's full list of 2022 Scientific Achievement Award recipients here:

https://t.co/HGMOVYIleO

[3T Biosciences @3tbio]

Leah Sibener, co-founder and Head of Therapeutic Discovery at @3tbio, will speak at the 2nd TCR-based Therapies Summit this week. Session on identifying TCR specificity and cross-reactivity. More info at https://t.co/vIsEWKpea1 #TCRbasedTherapiesSummit @CAR_TCell

[3T Biosciences @3tbio]

https://t.co/UHYTK0vQbb
There's ONE WEEK LEFT to join my session at #FOBUSA2021! Join biologics innovators at the hub for the life science community, where academia and industry meet to improve patient health. Register FREE using my special code!

[3T Biosciences @3tbio]

Hope to see you (in the partnering system) at the #BioComGlobalPartnering conference this week. Thanks to @BIOCOMCEO Joe Panetta and team at @biocom for continuing to organize this great event. We’re hopeful to be back in Torrey Pines next year! #celltherapy #biotech

[3T Biosciences @3tbio]

Join @3tbio at the #SVBLeerinkGlobalHealthcareConference as CEO John Connolly aka @hotirishmonkey presents an update. Hanspeter Gerber, CSO, and Glenn Dourado, CBO, are taking meetings as well. @SVBLeerink #celltherapy #genetherapy #biotech

[3T Biosciences @3tbio]

Learn more about @3tbio and our 3T-TRACE technology! Company presentation by @hotirishmonkey at the #BIOCEO21 Digital Conference! On-demand at https://t.co/9nGGcMYbgT @IAmBiotech #CellTherapy #GeneTherapy

[3T Biosciences @3tbio]

@3tbio is proud to be a presenting company at the #BiotechShowcase digital conference. CEO John Connolly aka @hotirishmonkey and CSO Hanspeter Gerber have been actively taking meetings this week with investors and potential partners #biotech #CellTherapy #GeneTherapy

[3T Biosciences @3tbio]

@3tbio appoints John Connolly as interim #CEO. Company to focus 3T-TRACE platform on novel target discovery and therapeutic development in pursuit of #SeriesA financing. More at https://t.co/3N6LbTv1z5 @parkerici #biotech #tcell #CellTherapy #GeneTherapy.

[WIRED @WIRED]

Happy #InternationalWomensDay! In honor of the day, meet just SOME of the women doing incredible things in science and technology.

First up: Donna Strickland, who recently became the first woman to win the Nobel Prize in physics in 55 years. 1/ https://t.co/93SXkRD9Jc

[Google @Google]

"Darkness cannot drive out darkness; only light can do that. Hate cannot drive out hate; only love can do that."

Today's #GoogleDoodle by artist @carefulblackgrl honors civil rights leader Martin Luther King Jr. → https://t.co/AVGT8wszCy #MLKDay

[Connecting African Women in STEM @cawstem]

Let's hear from you.
Just reply to this tweet using the hashtag #CAWSTEMConvos and #WhyILikeBeingaWomaninSTEM

Spill all the deets here on 'Why you like being a woman in STEM'

Did you also know it's #NationalSTEMDay today?

[HHS @HHSGov]

HHS celebrates those who have contributed to the science and health fields–especially the amazing female #STEM pioneers at HHS. Learn more about the exciting research happening around HHS: https://t.co/C6TcqF5KEb #NationalSTEMDay